Tag: Heptares Therapeutics

Sosei Group acquires candidate drugs to compensate for expected loss of patent protection for the Seebri inhaler in 2026 Heptares Therapeutics Ltd emerged from the MRC Laboratory of Molecular Biology at the University of Cambridge Sosei Group Corporation (そーせいグループ株式会社) is a Japanese pharmaceutical group which mainly in-licenses pharmaceutica in Europe and North America, then brings…